Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AD26.COV2.S for Covid-19 immunisation: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 190 adverse event reports in the FDA FAERS database where AD26.COV2.S was used for Covid-19 immunisation.

Most Reported Side Effects for AD26.COV2.S

Side Effect Reports % Deaths Hosp.
Covid-19 58 13.4% 0 18
Fatigue 47 10.9% 0 12
Off label use 43 9.9% 0 13
Headache 42 9.7% 0 6
Pain 41 9.5% 0 18
Pyrexia 40 9.2% 0 11
Malaise 38 8.8% 0 12
Arthralgia 32 7.4% 0 11
Chills 31 7.2% 0 8
Nausea 25 5.8% 0 9
Pain in extremity 24 5.5% 1 5
Covid-19 immunisation 22 5.1% 0 6
Diarrhoea 21 4.9% 0 8
Drug ineffective 20 4.6% 0 4
Feeling abnormal 20 4.6% 0 3

Other Indications for AD26.COV2.S

Immunisation (113) Covid-19 prophylaxis (64) Product used for unknown indication (37)

Other Drugs Used for Covid-19 immunisation

TOZINAMERAN (4,585) COVID-19 VACCINE NOS (1,641) ELASOMERAN (1,258) AZD-1222 (1,166) CX-024414 (385) COVID-19 VACCINE (305) NIRMATRELVIR\RITONAVIR (108) RAXTOZINAMERAN (43) BRETOVAMERAN (39) UNSPECIFIED INGREDIENT (25)

Related Pages

AD26.COV2.S Full Profile All Covid-19 immunisation Drugs AD26.COV2.S Demographics AD26.COV2.S Timeline